Location History:
- Suwon, KR (1995)
- Kyungki-do, KR (1999)
Company Filing History:
Years Active: 1995-1999
Title: Innovations in Pharmaceutical Delivery by Inventor Kee An Um
Introduction
Kee An Um is an esteemed inventor based in Kyungki-do, South Korea. With a remarkable record of two patents to his name, he has made significant contributions to the field of pharmaceutical compositions, particularly focusing on enhancing drug delivery methods.
Latest Patents
Kee An Um's latest patents showcase innovative strategies for improving medicine administration. The first patent, titled "Transdermal delivery matrix for piroxicam," presents a pharmaceutical composition designed to enhance percutaneous absorbability using absorption assistants. This invention significantly increases the permeation and dissolution rates of piroxicam while featuring a unique absorption assistant that allows for excessively incorporating the active substance into an adhesive matrix.
His second patent is titled "Method for preparing enteric-coated oral drugs containing acid-unstable" and relates to developing enteric-coated oral medications. This method utilizes an inclusion complex formed by reacting benzimidazole derivatives with cyclodextrin in an alkaline solution, ensuring the stability of acid-unstable compounds.
Career Highlights
Kee An Um currently works with Sunkyong Industries Co., Ltd., where he applies his expertise in pharmaceutical innovations. His extensive background and dedication to research in pharmaceutical sciences have enabled him to develop groundbreaking technologies that enhance drug delivery systems.
Collaborations
Throughout his career, Kee An Um has collaborated with notable coworkers, including Dong S Min and Yong Soo Kim. These partnerships have facilitated a collective effort to advance research in the field and improve the effectiveness of drug formulations.
Conclusion
Kee An Um’s contributions to pharmaceutical innovations mark a significant milestone in the evolution of drug delivery systems. His impressive patents reflect a commitment to improving patient outcomes through advanced medical formulations.